Cambridge Investment Research Advisors, Inc. Lifevantage Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Lifevantage Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,446 shares of LFVN stock, worth $178,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,446Holding current value
$178,417% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LFVN
# of Institutions
82Shares Held
4.15MCall Options Held
34.9KPut Options Held
7K-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$13.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA474KShares$8.1 Million0.0% of portfolio
-
Capital Management Corp302KShares$5.15 Million1.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX273KShares$4.66 Million0.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC211KShares$3.6 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $215M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...